Ubtech Ships First Consumer Humanoids as 13,000 Pre-Orders Test Mass-Market Ambition

Ubtech starts U1 deliveries with 13,000 orders; H1 revenue up 104.2%, but shares near 52-week low.

The gap between Ubtech Robotics' operational trajectory and its share price has rarely looked wider. The Shenzhen-based company on Thursday began delivering its U1 humanoid robot series to customers, with distribution partners having filed more than 13,000 orders for the model line — the clearest signal yet that the Chinese manufacturer's push beyond industrial and research settings is gaining commercial traction.

The U1, unveiled in June alongside the Cruzr Y1 and Walker C1 models, targets the home and consumer segment. Cruzr Y1 is built for industrial manufacturing, while Walker C1 serves commercial service roles. With U1 now shipping, Ubtech is effectively stepping out of its established niche and into a considerably larger addressable market.

Half-Year Numbers Show Acceleration

The delivery launch arrives on the back of interim results published in late August that underscore how quickly the business is scaling. Revenue for the first half of 2026 climbed 104.2 percent to 1.269 billion renminbi, with gross profit jumping 160.9 percent to 567 million renminbi. The net loss narrowed 23.0 percent to 339 million renminbi, while the adjusted EBITDA loss contracted by 45.9 percent.

The standout figures come from the core humanoid robotics segment featuring embodied AI. Unit sales of full humanoid robots surged 1,946.7 percent to 921 units in the period, generating revenue of 590 million renminbi — a 1,445.0 percent increase year on year. Across all humanoid robot models, Ubtech moved 16,123 units, up 268.3 percent from the prior-year period. Research and development spending exceeded 300 million renminbi during the same stretch, with the engineering team expanding to 1,103 staff.

Partnerships and a State Contract Broaden the Base

Ubtech has been busy extending its ecosystem beyond its own product pipeline. At the World Robot Conference in August, the company signed a memorandum of understanding with Singapore's Singtel to develop enterprise applications pairing Ubtech's humanoids with the telecom operator's 5G network and corporate customer base.

Days earlier, Ubtech struck a cooperation agreement with BASiC Semiconductor focused on silicon carbide chips for platforms exceeding 96 volts — technology that could power more capable actuators in future robot generations. August also saw Ubtech complete the acquisition of a 43.01 percent stake in Fenglong Shares, taking control of the company, which has been consolidated into the group's accounts since April 2026.

Reuters has separately reported that Ubtech won an 18 million US dollar contract last October from the Guangxi regional government to equip a humanoid robot training facility with hardware. While not new, the order remains a useful marker of demand from public-sector buyers alongside private customers.

Market Remains Unimpressed

None of this operational momentum has translated into share-price performance. The stock closed Thursday at 8.81 euros, down 2.1 percent on the day. It now sits roughly 39 percent below its level at the start of the year and about 48 percent beneath its 52-week high of 17.00 euros, reached in January. The gap to the 52-week low of 8.50 euros from late July is a slender 3.7 percent, leaving the shares hovering near their annual trough.

The disconnect between surging unit sales and a languishing valuation reflects a market that is still weighing whether Ubtech can convert scale into profitability. The company is selling meaningfully more robots, but it remains loss-making, and the capital intensity of humanoid manufacturing raises questions about how quickly margins can improve. Sector-wide volatility has also weighed on sentiment, hitting other Chinese robotics names in recent months.

For now, the combination of rapidly growing volumes, a shrinking deficit and fresh public-sector contracts gives the growth narrative substance. Whether that translates into share-price stabilisation depends on Ubtech's ability to accelerate its path to profitability in the quarters ahead.